Prognostic significance of the mRNA expression of ERCC1, RRM1, TUBB3 and TYMS genes in patients with non-small cell lung cancer

By            

Experimental and Therapeutic Medicine, Vol. 10, Iss. 3, 2015-01 ,pp. : 937-941

Spandidos Publications

Access to resources Recommend Favorite

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients

By                        

Oncology Reports, Vol. 30, Iss. 5, 2013-01 ,pp. : 2385-2398

Spandidos Publications

Access to resources Recommend Favorite

EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in nonsmall cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy

By                    

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1123-1128

Science Publishers

Access to resources Recommend Favorite

Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy

By                    

Molecular Medicine Reports, Vol. 11, Iss. 5, 2015-01 ,pp. : 3523-3532

Spandidos Publications

Access to resources Recommend Favorite

Excision repair cross complementation group 1 is a chemotherapy-tolerating gene in cisplatin-based treatment for non-small cell lung cancer

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-02 ,pp. : 809-817

Spandidos Publications

Access to resources Recommend Favorite